Short Interest in CV Sciences, Inc. (OTCMKTS:CVSI) Declines By 70.0%

CV Sciences, Inc. (OTCMKTS:CVSI) was the recipient of a large drop in short interest during the month of June. As of June 30th, there was short interest totalling 25,900 shares, a drop of 70.0% from the June 15th total of 86,300 shares. Based on an average daily trading volume, of 641,900 shares, the short-interest ratio is currently 0.0 days.

CV Sciences Price Performance

CV Sciences stock remained flat at $0.05 during mid-day trading on Friday. The company had a trading volume of 284,845 shares, compared to its average volume of 314,366. CV Sciences has a 12 month low of $0.03 and a 12 month high of $0.10. The firm’s 50-day simple moving average is $0.06 and its 200-day simple moving average is $0.05. The firm has a market capitalization of $9.06 million, a PE ratio of -2.50 and a beta of 0.61.

CV Sciences Company Profile

CV Sciences, Inc develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol (CBD) in North America. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The company offers its products under the PlusCBD, ProCBD, HappyLane, CVAcute, CVDefense, and PlusCBD Pet brands in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, elect distributors, brick and mortar retailers, and select e-tailers.